Healthcare -
Biotechnology - NASDAQ - US
$ 2.01
8.65 %
$ 166 M
Market Cap
-1.3
P/E
STRO - REVENUE
Revenue STRO - Sutro Biopharma, Inc.
154 M
LAST VALUE
57.62%
2 YEAR CAGR
31.96%
5 YEAR CAGR
0.00%
10 YEAR CAGR